Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cesra Arzneimittel is a German pharmaceutical company specializing in the development and manufacture of phytopharmaceuticals and high-quality skincare products. Based in Baden-Baden and founded in 1929, the company is widely recognized for its flagship product, Aescuven, which utilizes horse chestnut seed extract to treat chronic venous insufficiency. Beyond vascular health, Cesra is a leader in herbal dermatology, notably through its Ilon brand of ointments for skin inflammation and abscesses. The company operates as part of the Redel Foundation, dedicating a significant portion of its profits to humanitarian aid and global health projects. Cesra maintains a strong focus on natural ingredients backed by scientific research, distributing its portfolio to pharmacies and healthcare providers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aescuven Pharma Deutschland.